# Compass Therapeutics (CMPX) — Analyst Forecast

CMPX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cmpx/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $12.00 |
| Sep 23, 2026 | Wedbush | Downgraded | Outperform → Neutral | $1.00 |
| Sep 23, 2026 | Citizens | Maintained | Market Outperform | $4.00 |
| Sep 23, 2026 | Craig-Hallum | Maintained | Buy | $8.00 |
| Sep 23, 2026 | Guggenheim | Maintained | Buy | $4.00 |
| Aug 7, 2026 | Piper Sandler | Maintained | Overweight | $6.00 |
| Apr 28, 2026 | Canaccord Genuity | Maintained | Buy | $7.00 |
| Apr 28, 2026 | Citizens | Maintained | Market Outperform | $10.00 |
| Apr 27, 2026 | D. Boral Capital | Maintained | Buy | $30.00 |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | $24.00 |
| Mar 24, 2026 | Guggenheim | Maintained | Buy | $12.00 |
| Jan 6, 2026 | D. Boral Capital | Maintained | Buy | $30.00 |
| Jan 5, 2026 | William Blair | Initiated Coverage | Outperform | — |
| Dec 3, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Dec 3, 2025 | Canaccord Genuity | Initiated Coverage | Buy | $10.00 |
| Dec 3, 2025 | Citizens | Initiated Coverage | Market Outperform | $10.00 |
| Nov 5, 2025 | D. Boral Capital | Maintained | Buy | $30.00 |
| Oct 6, 2025 | LifeSci Capital | Initiated Coverage | Outperform | $10.00 |
| Aug 12, 2025 | D. Boral Capital | Maintained | Buy | $32.00 |
| Aug 12, 2025 | Guggenheim | Maintained | Buy | $12.00 |

## Frequently Asked Questions

### What is the latest analyst rating on CMPX?

On Sep 23, 2026, HC Wainwright & Co. maintained Compass Therapeutics at Buy with a price target of $12.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).